The aim of this webinar is to teach healthcare professionals about the current and future use of personalised medicine in Cystic Fibrosis (CF) and Bronchiectasis. Delegates will hear from world-leading clinical academics on the topics of CF in children, CF in adults and bronchiectasis. Discussions will include the most recent clinical trial data, to ensure that all viewers are familiar with the latest evidence-based medicine in CF and bronchiectasis.
The learning objectives will be as follows:
A CPD certificate with CPD credit will be issued to those joining each webinar live and will be automatically issued after 7 days to those who watched the webinar live in its entirety. Those who watch the webinar on-demand will receive a CPD certificate 30 days after the webinar has gone live.
Join in the conversation online using #RSMLive
Follow us on Twitter: @RoySocMed
We would like to thank our sponsor PARI for their support of this webinar. Please note that the scientific programme and content has not been influenced in any way by the sponsor.
Professor of Respiratory Medicine at University of Dundee; British Lung Foundation Chair of Respiratory Research
Prof James Chalmers is a Professor and Consultant Respiratory Physician at the University of Dundee. He is also the BLF Chair of Respiratory Research. James' research focuses on developing personalised approaches in the management of bronchiectasis. He has published extensively and delivered numerous international talks about this topic.
Professor of Paediatric Respiratory Medicine at the National Heart and Lung Institute; Clinical Lead of the UK CF Gene Therapy Consortium
Professor Jane Davies is a Professor and Consultant in Paediatric Respiratory Medicine at the Royal Brompton Hospital. Jane's research focuses on developing targeted therapies for cystic fibrosis, and she has been involved in numberous clinical trials in this area. She is also the lead of the UK CF Gene Therapy consortium.
Professor or Pulmonary, Allergy and Critical Care Medicine; Director of the Cystic Fibrosis Research Centre
Professor Steven Rowe is a Professor and respiratory paediatrician. He is a world-leading expert in cystic fibrosis, and has been at the forefront of numerous clinical trials of CFTR modulator therapies. As Director of the Cystic Fibrosis Research Centre, Steven has extensive experience in the field of personalised medicine in cystic fibrosis.
Associate Professor of Pulmonary, Allergy and Critical Care Medicine; Director of the Adult Cystic Fibrosis Programme at the University of Alabama
Dr George Solomon is an Associate Professor and respiratory physician. Dr Solomon has been the lead principal investigator for several CFTR modulator trials. As Director of the Adult CF Programme at the University of Alabama, he has extensive experience managing complex CF and bronchiectasis patients.
Airway clearance innovation in patients with Bronchiectasis given by Mr Laurent Morin, Medical Affairs Director, Physio-Assist
Professor James Chalmers - Professor of Respiratory Medicine at University of Dundee; British Lung Foundation Chair of Respiratory Research
Professor Jane Davies - Professor of Paediatric Respiratory Medicine at the National Heart and Lung Institute; Clinical Lead of the UK CF Gene Therapy Consortium
Professor Steven Rowe - Professor of Pulmonary, Allergy and Critical Care Medicine; Director of the Cystic Fibrosis Research Centre. Dr George Solomon - Associate Professor of Pulmonary, Allergy and Critical Care Medicine; Director of the Adult Cystic Fibrosis Programme at the University of Alabama
Professor James Chalmers, Professor Jane Davies and Dr George Solomon
Online
*Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.
Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place.
This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
